Please select the option that best describes you:
Topics:
Gynecologic Cancers • Ovarian Cancer
Would you hold a PARP inhibitor in the perioperative period for an ileostomy reversal in a patient who has completed primary debulking surgery followed by chemotherapy?
If so, for how long? What is your general practice for managing PARP inhibitors in the peri-operative period?